Tusk Therapeutics appoints Matthew Hall as Chief Financial Officer

London and Stevenage, UK – 14 September 2017: Tusk Therapeutics, an immuno-oncology company, is pleased to announce the appointment of Matthew Hall as Chief Financial Officer. Matthew is a seasoned finance professional with over 20 years’ corporate finance experience in a number of leading organisations and fast growing companies.  Most recently Chief Financial Officer at Simbec-Orion Group, Matthew has extensive … Read More